BR9908825A - Forma cristalina de paroxetina - Google Patents

Forma cristalina de paroxetina

Info

Publication number
BR9908825A
BR9908825A BR9908825-8A BR9908825A BR9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A
Authority
BR
Brazil
Prior art keywords
paroxetine
crystalline form
free
crystalline
therapy
Prior art date
Application number
BR9908825-8A
Other languages
English (en)
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaine
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9908825A publication Critical patent/BR9908825A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMA CRISTALINA DE PAROXETINA" Base livre de paroxetina pura, cristalina, por exemplo, e isenta de solvente; e o seu emprego na terapia para tratar depressão.
BR9908825-8A 1998-03-16 1999-03-16 Forma cristalina de paroxetina BR9908825A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (1)

Publication Number Publication Date
BR9908825A true BR9908825A (pt) 2000-11-21

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908825-8A BR9908825A (pt) 1998-03-16 1999-03-16 Forma cristalina de paroxetina

Country Status (18)

Country Link
EP (1) EP1064282A1 (pt)
JP (1) JP2002506865A (pt)
KR (1) KR20010041947A (pt)
CN (1) CN1300286A (pt)
AP (1) AP2000001907A0 (pt)
AU (1) AU2847199A (pt)
BG (1) BG104839A (pt)
BR (1) BR9908825A (pt)
CA (1) CA2323896A1 (pt)
EA (1) EA200000946A1 (pt)
HU (1) HUP0101215A3 (pt)
ID (1) ID27596A (pt)
IL (1) IL138390A0 (pt)
NO (1) NO20004583L (pt)
PL (1) PL342931A1 (pt)
SK (1) SK13622000A3 (pt)
TR (1) TR200002675T2 (pt)
WO (1) WO1999047519A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) * 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion

Also Published As

Publication number Publication date
ID27596A (id) 2001-04-12
CN1300286A (zh) 2001-06-20
HUP0101215A2 (hu) 2002-04-29
KR20010041947A (ko) 2001-05-25
SK13622000A3 (sk) 2001-03-12
BG104839A (en) 2001-09-28
NO20004583D0 (no) 2000-09-14
TR200002675T2 (tr) 2000-12-21
HUP0101215A3 (en) 2002-05-28
PL342931A1 (en) 2001-07-16
JP2002506865A (ja) 2002-03-05
NO20004583L (no) 2000-09-15
AU2847199A (en) 1999-10-11
IL138390A0 (en) 2001-10-31
CA2323896A1 (en) 1999-09-23
WO1999047519A1 (en) 1999-09-23
AP2000001907A0 (en) 2000-09-30
EP1064282A1 (en) 2001-01-03
EA200000946A1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
BR0014076A (pt) Benzamidas e inibidores correlatos do fator xa
BR0014384A (pt) Compostos para o tratamento da isquémia
ATE331534T1 (de) Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs
SE0101387D0 (sv) Novel compounds
MEP8209A (en) Modified factor viii
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR9912376A (pt) Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato.
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ATE68977T1 (de) Pharmazeutisch aktive konjugate mit spezifitaet fuer die bindung an koerpergewebe.
SE9802208D0 (sv) Novel compounds
BR9909118A (pt) Composição farmacêutica, comprimido, forma de dosagem unitária farmacêutica sólida estável, e, processo para tratar depressão em um mamìfero
BR0213072A (pt) Sabonete em barra
BR0208353A (pt) Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças
BR0115036A (pt) Processo para a preparação de um composto
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
BR9815098A (pt) Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
TR200101693T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
SE9802209D0 (sv) Novel compounds
ES2088877T3 (es) Procedimiento de preparacion del 3-pirrolidinol.
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]